BlueRock Therapeutics

BlueRock Therapeutics is a clinical-stage cell therapy company focused on developing cellular medicines to treat a variety of diseases, primarily focusing on neurological, cardiovascular, immunological, and ophthalmic conditions. They are harnessing the power of cell therapy to create a pipeline of new medicines for patients suffering from degenerative diseases. Their lead clinical program, bemdaneprocel (BRT-DA01) is in Phase I clinical trials for Parkinson's disease. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer, and became a wholly owned subsidiary of Bayer in 2019.

BlueRock's approach centers around using pluripotent stem cells (PSCs) to develop highly specific cell types with the intention of replacing those lost or damaged due to disease. They specialize in induced pluripotent stem cells (iPSCs), which can be reprogrammed into highly specific cell types. The company is driven by a mission to transform the way diseases are treated and has a strong emphasis on collaboration, partnering with other companies and institutions to advance their research.

BlueRock Therapeutics offers a flexible work arrangement and time off, allowing employees to balance their work and personal lives. While details about specific programs may differ across locations, the company provides a generous paid holiday schedule, sick and personal time, and encourages a culture of work-life balance.

BlueRock Therapeutics offers a comprehensive benefits package that includes health insurance with HRA and HSA options, dental and vision coverage, FSA, HSA, and Wellness Spending Accounts, as well as fitness reimbursement. They also provide peace-of-mind benefits such as retirement savings plan with company match, life and accidental death and dismemberment insurance, short and long-term disability insurance, and an employee assistance program. In addition, BlueRock offers generous paid time off, including sick leave, personal time, flexible working arrangements, and a generous paid holiday schedule. The specific offerings may vary depending on the location, however, the company strives to provide competitive benefits that support the health and well-being of its employees and their families.

BlueRock Therapeutics is a clinical-stage cell therapy company dedicated to discovering and developing revolutionary cellular medicines that can fundamentally change how devastating diseases are treated. They aim to improve the lives of patients suffering from neurological, cardiovascular, immunological, and ophthalmic diseases by harnessing the power of cell therapy to replace damaged or lost cells, effectively restoring functionality and reimagining what's possible with cellular medicine.

BlueRock Therapeutics cultivates a culture of innovation and collaboration, characterized by a shared passion for scientific discovery and the relentless pursuit of transformative cell therapies. They value urgency in tackling the complex challenges of degenerative diseases, integrity in their approach to research and development, a strong sense of community fostered by respect, trust, and collaboration, and the courage to persist in the face of adversity.

BlueRock Therapeutics fosters a culture of diversity, equity, and inclusion, believing that a diverse workforce strengthens innovation and problem-solving. They emphasize building a community rooted in trust, curiosity, and respect, recognizing the importance of unique ideas, backgrounds, and experiences. Their community is an interdisciplinary ecosystem with a singular focus on developing life-changing cell therapies. They aim to create an environment where all employees feel a sense of belonging, are empowered to contribute, and have opportunities to grow and thrive.